INCY peers and competitors
Incyte Corporation · end-of-day data as of Oct 16, 2026
Incyte Corporation
$113.07-3.9%
Hold · 29 analystsPT $128.39 +13.6%
INCY’s peers by industry and size include Vertex Pharmaceuticals (VRTX), Moderna (MRNA) and Regeneron Pharmaceuticals (REGN). Among these 12 companies INCY ranks 8th by market cap ($22.92B); its P/E of 14.4 compares with a median of 27.2 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $499.74 | -1.8% | -10.4% | +14.0% | 29.1 | $127B | |
| 2 |  | $218.01 | -7.8% | -7.8% | -25.0% | — | $87.04B | |
| 3 |  | $790.74 | -0.7% | -7.2% | +8.7% | 19.6 | $81.41B | |
| 4 |  | $231.83 | -0.9% | -52.8% | +61.5% | 39.2 | $31.02B | |
| 5 |  | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | |
| 6 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 7 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B | |
| 8 | | $113.07 | -0.2% | -13.0% | +13.6% | 14.4 | $22.92B | |
| 9 |  | $222.66 | -0.7% | -16.4% | +24.2% | 27.2 | $21.71B | |
| 10 |  | $18.66 | +2.4% | 0.0% | +9.8% | — | $21.43B | |
| 11 |  | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | |
| 12 |  | $72.57 | +0.1% | -0.1% | -7.0% | 62.6 | $11.38B |
Data as of Oct 16, 2026 close.